Stock PMCB PHARMACYTE BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart PharmaCyte Biotech, Inc.

Equities

PMCB

US71715X2036

Real-time Estimate Cboe BZX
Other stock markets
 20:13:51 12/06/2024 BST 		5-day change 1st Jan Change
2.285 USD 0.00% Intraday chart for PharmaCyte Biotech, Inc. +16.75% +7.41%
05-23 MyMD Pharmaceuticals, Inc. announced that it has received $14 million in funding from PharmaCyte Biotech, Inc. CI
05-20 MyMD Pharmaceuticals, Inc. announced that it expects to receive $14 million in funding from PharmaCyte Biotech, Inc. CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PHARMACYTE BIOTECH, INC. Stock PharmaCyte Biotech, Inc.
 19.32M - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 780B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 627B
MERCK & CO., INC. Stock Merck & Co., Inc.
 334B
ABBVIE INC. Stock AbbVie Inc.
 296B
ASTRAZENECA PLC Stock AstraZeneca PLC
 244B
  1. Stock Market
  2. Equities
  3. PMCB Stock
  4. Charts PharmaCyte Biotech, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW